Question-and-Answer Session
Operator
[Operator Instructions].
Our first question comes from Adam Holt with JP Morgan.
Adam Holt - JP Morgan
Good morning, and thanks for taking my question. I had two questions on the core business, the IDD business. You've mentioned that it would reaccelerate to grow in the quarter, and I was wondering, that the comparison should get easier as we head into the back half of the year. Obviously you are starting to see much better upgrade activity within 65% of the base now on XI. Could you talk a little bit about what your expectations are for growth maybe even accelerating a little bit in the back half and are you past the inflection point with the upgrade, within the installed base where you are starting to see a lot more new module attached as well?
John Schwarz - Chief Executive Officer
Well, I would characterize the progress as steady, and as against our targets that we have established, in fact more than two years ago, now that we first launched the XI platform. And so, the progress is on plan, the progress is enabled by additional releases that have lodged into the marketplace over the last six to nine months. And it's kind of where we expected and forecasted it to be. I would caution against assuming a significant acceleration, if you will, but rather project on a trajectory that we have been on for the past two or three quarters.
Adam Holt - JP Morgan
And if I could just ask a follow-up on the Cartesis guidance looking forward, could you talk a little bit about what some of the assumptions are for synergies, either revenue synergies brought from the transaction or cost synergies? Thanks very much.
John Schwarz - Chief Executive Officer
Let me start on the cost side. Obviously, the restructuring charges announced in some of the rather aggressive return to an accretive mode of operation will signal that we are intending to execute fairly aggressive, inspiration [ph] strategy including elimination of some overlaps and duplicate costs. So, a lot of work being done on that score. There isn’t a lot of overlap on the product side, as we suggested. However, as in any case, there are overlaps in G&A structure, overlaps in some of our go-to-markets operations and in customer support. And those are being eliminated on a rapid timescale.
As far as co-studying [ph] the synergies, that was one of the driving justification for the acquisition. We believe that the 200 or so, consultants that Cartesis brings to the table, especially since the majority of them are located in New York, we expect we substantially extend our footprint in the EMEA marketplace. In so far as the expansion of the selling capability, we expect to take our EPM sales force, which is particularly strong in North America and help Cartesis with selling in the U.S. and Canada, potentially in the Latin Americas as well. While Cartesis will help us in Europe, with selling EPM because they had a strong team over there, we are building our Asian team pretty much from scratch in that neither Cartesis small Business Objects core has had a lot of EPM presence there today. So that’s still a market to be invested in. So just a same, a significant selling as well as cost synergies are expected and are planned on.
- To read the full transcript on Seeking Alpha, click here »
